skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer

Journal Article · · Biochemical and Biophysical Research Communications
; ; ;  [1];  [2]
  1. Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081 (China)
  2. Department of Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086 (China)

Cervical cancer is one of the most common carcinomas in the female reproductive system. Treatment of cervical cancer involves surgical removal and chemotherapy. Resistance to platinum-based chemotherapy drugs including cisplatin has increasingly become an important problem in the treatment of cervical cancer patients. We found in this study that stanniocalcin 2 (STC2) expression was upregulated in both cervical cancer tissues and cell lines. The levels of STC2 expression in cervical cancer cell lines were positively correlated with the rate of cell proliferation. Furthermore, in cisplatin resistant cervical cancer cells, the levels of STC2 expression were significantly elevated. Modulation of STC2 expression by siRNA or overexpression in cisplatin resistant cells resulted in altered cell survival, apoptosis, and cisplatin resistance. Finally, we found that there was significant difference in the activity of the MAPK signaling pathway between cisplatin sensitive and resistant cervical cancer cells, and that STC2 could regulate the activity of the MAPK signaling pathway. - Highlights: • STC2 was upregulated in cervical cancer and promoted cervical cancer cell proliferation. • Cisplatin resistant cells had elevated STC2 levels and enhanced proliferation. • STC2 regulated cisplatin chemosensitivity in cervical cancer cells. • STC2 regulated the activity of the MAPK signaling pathway.

OSTI ID:
22592765
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 466, Issue 3; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression
Journal Article · Fri Feb 07 00:00:00 EST 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22592765

ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells
Journal Article · Sat Jun 03 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22592765

Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell
Journal Article · Fri Jul 13 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22592765